BMRN News and Press, BioMarin Pharmaceutical Inc. From 02/24/26

BioMarin to Participate in Four Upcoming Investor Conferences in March PR Newswire TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 Leerink 2026 Global Healthcare Conference on Monday, March 9, 2026 Jefferies 2026 Biotech on the Beach Summit on Tuesda...

2026-02-23 23:15:27 ET More on BioMarin Pharmaceutical BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call Transcript BioMarin Pharmaceutical Inc. 2025 Q4 - Results - Earnings Call Presentation The Right Play On BioMarin Pharmaceuticals BioMarin Pharmac...

2026-02-23 23:14:58 ET BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call February 23, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call Transcript

2026-02-23 16:09:44 ET Read the full article on Seeking Alpha For further details see: BioMarin Pharmaceutical Non-GAAP EPS of $0.46 misses by $0.10, revenue of $875M beats by $39.97M

2026-02-20 17:35:49 ET More on BioMarin Pharmaceutical The Right Play On BioMarin Pharmaceuticals 44th Annual J.P. Morgan Healthcare Conference BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript BioMarin p...

OGE Energy Corp (OGE) is expected to report $0.3 for Q4 2025 Dana Incorporated (DAN) is expected to report $0.32 for Q4 2025 SiriusPoint Ltd. (SPNT) is expected to report $0.54 for Q4 2025 Nutrien Ltd. (NTR) is expected to report $0.82 for Q4 2025 Broadstone Net Lease Inc. (BNL) i...

BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ET PR Newswire SAN RAFAEL, Calif. , Feb. 17, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Ha...

BioMarin Announces Closing of Private Offering of Senior Notes PR Newswire SAN RAFAEL, Calif. , Feb. 12, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it closed its previously announced offering of $850 million of 5.500% senior...

2026-02-06 07:04:33 ET from Piper Sandler issued a price target of $84.00 for BMRN on 2026-02-06 11:51:57. The adjusted price target was set to $84.00. At the time of the announcement, BMRN was trading at $57.15. The overall price target consensus is at $80.09 with high ...

2026-02-03 08:52:33 ET Xeris Pharmaceuticals' ( XERS ) shares have surged nearly 100% year-over-year (YoY) as a result of both strong and accelerating commercial revenue growth, improving operational discipline, and positive results from its pipeline. Today, Xeris represents mor...